Abstract: To achieve in vivo repair of severed mammalian nerve tissue, a system can be employed to induce distraction neurogenesis. At least a portion of the system can be anchored at an injury site, such as between distal and proximal nerve ends. The system can be attached to the proximal nerve end and can place the nerve under micro-tension for an extended period of treatment. The system may also deliver medication or treatment to encourage neurogenesis and to reduce pain in the subject receiving treatment. After the course of treatment, the device can be removed from the injury site, and the nerve ends rejoined.
Type:
Grant
Filed:
April 11, 2023
Date of Patent:
February 11, 2025
Assignee:
Axsonus LLC
Inventors:
Jason Bourgeois, Michael L. Wach, Frank Lau
Abstract: To achieve in vivo repair of severed mammalian nerve tissue, a system can be employed to induce distraction neurogenesis. At least a portion of the system can be anchored at an injury site, such as between distal and proximal nerve ends. The system can be attached to the proximal nerve end and can place the nerve under micro-tension for an extended period of treatment. The system may also deliver medication or treatment to encourage neurogenesis and to reduce pain in the subject receiving treatment. After the course of treatment, the device can be removed from the injury site, and the nerve ends rejoined.
Type:
Grant
Filed:
July 4, 2019
Date of Patent:
September 19, 2023
Assignee:
Axsonus LLC
Inventors:
Jason Bourgeois, Michael L. Wach, Frank Lau